Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer

Purpose. This randomized phase 2 study sought to assess the treatment effect of a finite duration of apalutamide with and without androgen deprivation therapy (ADT) in biochemically recurrent prostate cancer (BCR PC). Materials and Methods. Patients with BCR PC after primary definitive therapy and p...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Rahul Aggarwal, Joshi J. Alumkal, Russell Z. Szmulewitz, Celestia S. Higano, Alan H. Bryce, Angela Lopez-Gitlitz, Sharon A. McCarthy, Branko Miladinovic, Kelly McQuarrie, Shibu Thomas, Ke Zhang, Eric J. Small
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2022-01-01
Schriftenreihe:	Prostate Cancer
Online-Zugang:	http://dx.doi.org/10.1155/2022/5454727
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!